Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The reactive oxygen species (ROS)-related antioxidant defense system is a multi-layered biological network responsible for maintaining cellular redox balance by neutralizing excessive reactive oxygen and nitrogen species. This system comprises enzymatic antioxidants, such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), alongside non-enzymatic molecules like glutathione (GSH), ascorbic acid, and tocopherols (Halliwell & Gutteridge, 2015, Free Radicals in Biology and Medicine). These components function to prevent oxidative damage to lipids, proteins, and DNA, which otherwise leads to cellular dysfunction and death (Sies et al., 2017, Nature Reviews Molecular Cell Biology). Chronic imbalance, known as oxidative stress, is a hallmark of numerous pathologies, including neurodegenerative disorders, cardiovascular diseases, and cancer (Forman & Zhang, 2021, Nature Reviews Drug Discovery). Pharmacological modulation of this system often involves the use of Nrf2 activators, such as dimethyl fumarate, which induce a broad cytoprotective response, or direct-acting mimetics of antioxidant enzymes (He et al., 2020, Signal Transduction and Targeted Therapy). Despite its therapeutic potential, the system's complexity presents challenges, as ROS are also vital for physiological signaling, and excessive antioxidant intervention can paradoxically promote tumor progression or impair immune responses (Sayin et al., 2014, Science Translational Medicine).
Drugs targeting this system typically act by directly scavenging reactive species, providing precursors for antioxidant synthesis (e.g., glutathione), or activating transcription factors like Nrf2 to upregulate the expression of multiple antioxidant enzymes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species-related antioxidant defense systems (ROS-ADS).